These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23483648)

  • 41. Correlation between plan quality improvements and reduced acute dysphagia and xerostomia in the definitive treatment of oropharyngeal squamous cell carcinoma.
    Cui T; Ward MC; Joshi NP; Woody NM; Murray EJ; Potter J; Dorfmeyer AA; Greskovich JF; Koyfman SA; Xia P
    Head Neck; 2019 Apr; 41(4):1096-1103. PubMed ID: 30702180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx.
    Teguh DN; Levendag PC; Noever I; van Rooij P; Voet P; van der Est H; Sipkema D; Sewnaik A; Baatenburg de Jong RJ; de la Bije D; Schmitz PI
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1119-27. PubMed ID: 18472364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer.
    Anand AK; Chaudhoory AR; Shukla A; Negi PS; Sinha SN; Babu AA; Munjal RK; Dewan AK; Kumar K; Doval DC; Vaid AK
    Br J Radiol; 2008 Nov; 81(971):865-71. PubMed ID: 18941046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two-step Intensity-modulated Radiation Therapy for Oropharyngeal Cancer: Initial Clinical Experience and Validation of Clinical Staging.
    Tatebe H; Doi H; Ishikawa K; Kawakami H; Yokokawa M; Nakamatsu K; Kanamori S; Shibata T; Kitano M; Nishimura Y
    Anticancer Res; 2018 Feb; 38(2):979-986. PubMed ID: 29374730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereotactic body radiotherapy: a promising treatment option for the boost of oropharyngeal cancers not suitable for brachytherapy: a single-institutional experience.
    Al-Mamgani A; Tans L; Teguh DN; van Rooij P; Zwijnenburg EM; Levendag PC
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1494-500. PubMed ID: 21798672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes.
    Hunter KU; Schipper M; Feng FY; Lyden T; Haxer M; Murdoch-Kinch CA; Cornwall B; Lee CS; Chepeha DB; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):935-40. PubMed ID: 23040224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Target volume definition for intensity-modulated radiotherapy after induction chemotherapy and patterns of treatment failure after sequential chemoradiotherapy in locoregionally advanced oropharyngeal squamous cell carcinoma.
    Loo SW; Geropantas K; Wilson P; Martin WM; Roques TW
    Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):162-70. PubMed ID: 22906546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A prospective evaluation of patient-reported quality-of-life after (chemo)radiation for oropharyngeal cancer: which patients are at risk of significant quality-of-life deterioration?
    Al-Mamgani A; van Rooij P; Tans L; Verduijn GM; Sewnaik A; Baatenburg de Jong RJ
    Radiother Oncol; 2013 Mar; 106(3):359-63. PubMed ID: 23395066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing.
    Wendt TG; Abbasi-Senger N; Salz H; Pinquart I; Koscielny S; Przetak SM; Wiezorek T
    Radiat Oncol; 2006 Jun; 1():18. PubMed ID: 16790059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intensity-Modulated Radiation Therapy Alone Versus Intensity-Modulated Radiation Therapy and Brachytherapy for Early-Stage Oropharyngeal Cancers: Results From a Randomized Controlled Trial.
    Budrukkar A; Murthy V; Kashid S; Swain M; Rangarajan V; Laskar SG; Kannan S; Kale S; Upreti R; Pai P; Pantvaidya G; Gupta T; Agarwal JP
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1541-1551. PubMed ID: 37660737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy.
    Chen J; Pappas L; Moeller JH; Rankin J; Sharma PK; Bentz BG; Fang LC; Hayes JK; Shrieve DC; Hitchcock YJ
    Head Neck; 2007 Apr; 29(4):362-9. PubMed ID: 17163468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer.
    Sanguineti G; Sormani MP; Marur S; Gunn GB; Rao N; Cianchetti M; Ricchetti F; McNutt T; Wu B; Forastiere A
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):235-42. PubMed ID: 22104358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx.
    Rudoltz MS; Perkins RS; Luthmann RW; Fracke TD; Green TM; Moye L; Wludyka P; Choi YK; Ackerman SN
    Laryngoscope; 1999 Dec; 109(12):1967-73. PubMed ID: 10591356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.
    Fang FM; Tsai WL; Chen HC; Hsu HC; Hsiung CY; Chien CY; Ko SF
    Cancer; 2007 Jan; 109(2):313-21. PubMed ID: 17154159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy.
    Yu Y; Daly ME; Farwell DG; Luu Q; Gandour-Edwards R; Donald PJ; Chen AM
    Laryngoscope; 2015 Mar; 125(3):608-14. PubMed ID: 25215891
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.
    Weinstein GS; Quon H; O'Malley BW; Kim GG; Cohen MA
    Laryngoscope; 2010 Sep; 120(9):1749-55. PubMed ID: 20717944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cytoprotection with amifostine in the framework of radiochemotherapy in previously irradiated head and neck carcinoma].
    Büntzel J; Glatzel M; Schuth J; Weinaug R; Küttner K; Fröhlich D
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():37-40. PubMed ID: 10584140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of Intensity-Modulated Radiation Therapy on the Life Quality of Patients with Nasopharyngeal Carcinoma.
    Chen J; Liu P; Wang Q; Wu L; Zhang X
    Cell Biochem Biophys; 2015 Dec; 73(3):731-6. PubMed ID: 27259317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.